PATENT CLAIM ANALYSIS

Application Number: 16083408
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "007700"]

Abstract:
Disclosed is a highly efficient method for production of highly pure mutant-type human erythropoietin. The method is for production of mutant-type human erythropoietin, in which a transformed mammalian cell is allowed to produce the mutant-type human erythropoietin, and the supernatant of the culture is subjected to hydrophobic column chromatography, multimodal anion exchange column chromatography, anion exchange column chromatography, phosphate group affinity column chromatography, and gel filtration column chromatography, in this order.

Claim (Index 6):
The method for production according to  claim 1 , further comprising a step of subjecting the fraction collected in step (h) above to a virus elimination treatment or a virus inactivation treatment.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.90476
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15545194', '14416539', '14775248', '14352734', '14406192']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7636707023424325
- 35 USC 102 Novelty (BERT): 0.5150476601384774
- Combined Prediction Score: 0.738808398122037
- Mean Citation Score: 254.364098
- Max Citation Score: 262.02765
- Similarity Product: 152.49180360548797

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test